
Evaluating Launch Strategies for New Generation Drugs: Insights from Industry Experts
Examine the launch strategy for a new generation drug that matches or extends the indications of its predecessor. Gain insights into effective strategies, key challenges, and opportunities for transitioning from first to second-generation products, focusing on patient retention, product differentiation, and pricing strategies.
- US
- Europe
- Asia
- UK
- Japan
- Biopharma
- Pharma












